China Biologic Products (CBPO) Tops Q3 EPS by 19c

China Biologic Products (NASDAQ: CBPO) reported Q3 EPS of $1.38, $0.19 better than the analyst estimate of $1.19. Revenue for the quarter came in at $99.6 million versus the consensus estimate of $96.49 million.

For earnings history and earnings-related data on China Biologic Products (CBPO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• zSpace, Inc. (ZSPC) Reports Q2 results
• KULR Technology Group (KULR) Misses Q2 EPS by 39c